2012
DOI: 10.3748/wjg.v18.i48.7357
|View full text |Cite
|
Sign up to set email alerts
|

Serum pepsinogen II is a better diagnostic marker in gastric cancer

Abstract: Serum PG II concentration and PGI/PG II ratio are potential biomarkers for H. pylori-infected gastric disease. PG II is independently associated with risk of gastric cancer.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
20
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 30 publications
(23 citation statements)
references
References 30 publications
3
20
0
Order By: Relevance
“…In a study with a middle-aged male cohort of Japanese and following-up for 10 years, the results showed that the sensitivity and specificity of serum PG were low for the diagnosis of gastric cancer (Iino et al, 2012). The study in Chinese also showed a similar conclusion (Cao et al, 2012). Actually, PG is a serum marker of chronic atrophic gastritis, not an ideal indicator for the screening and diagnosis of gastric cancer.…”
Section: Pepsinogens (Pg)supporting
confidence: 51%
“…In a study with a middle-aged male cohort of Japanese and following-up for 10 years, the results showed that the sensitivity and specificity of serum PG were low for the diagnosis of gastric cancer (Iino et al, 2012). The study in Chinese also showed a similar conclusion (Cao et al, 2012). Actually, PG is a serum marker of chronic atrophic gastritis, not an ideal indicator for the screening and diagnosis of gastric cancer.…”
Section: Pepsinogens (Pg)supporting
confidence: 51%
“…On the basis of physiological aspect, both PGI and PGII were important to reflect gastric mucosal status. Increasing serum PGII level is noted in the status of active inflammation [37][38][39][40]. Longstanding chronic active gastritis gastric mucosal glands are destroyed and turned to atrophic gastritis that initially lead serum PGI decline, by the time progression further PGII is gradually decreased [27,41].…”
Section: Discussionmentioning
confidence: 99%
“…The quest for noninvasive methods to diagnose GC, the most feared complication of H. pylori infection, is one of the most active areas of research. Cao et al [15] deter-mined serum anti-H. pylori immunoglobulin G (IgG), pepsinogen I (PGI), and pepsinogen II (PGII) by ELISA in 450 patients with GC, 111 individuals with gastric atrophy, and 961 healthy controls. PGII levels were higher in patients with GC or gastric atrophy than in controls.…”
Section: Noninvasive Diagnosis Of Gastric Cancermentioning
confidence: 99%